Evoke Data Collection Study Germany

Prospective Data Collection to Evaluate the Feedback Control of the Saluda Medical's Evoke Spinal Cord Stimulation System in the Treatment of Patients With Chronic Pain of the Trunk and/or Limbs

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05272137

Enrollment

Registered

2022-03-09

Start date

2022-02-04

Completion date

2022-10-17

Last updated

2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Brief summary

The objective of this multicentre study is to collect electrophysiological and device data from the Evoke Closed-Loop SCS system in the treatment of chronic pain of the trunk and/or limbs, in a real world setting under normal conditions of use.

Interventions

DEVICEEvoke Spinal Cord Stimulation (SCS) System

A spinal cord stimulation system that measures and records evoked compound action potentials (ECAPs) and automatically adjusts the stimulation current to maintain a consistent ECAP amplitude

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient approval for data collection and transfer of de-identified data to sponsor.

Exclusion criteria

* No further

Design outcomes

Primary

Measure	Time frame	Description
ECAP Measurement in Microvolts	through 6 months post-implant	Evoked Compound Action Potentials (ECAPs) as a measure of spinal cord activation

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026